| Linda King | |
| Workplaces: | University of Oxford, Oxford Brookes University |
| Alma Mater: | University of Liverpool (BSc) University of Oxford (DPhil) |
| Thesis2 Title: | )--> |
| Thesis1 Url: | and |
| Thesis2 Url: | )--> |
| Thesis1 Year: | and |
| Thesis2 Year: | )--> |
| Doctoral Advisors: | )--> |
| Spouses: | )--> |
| Partners: | )--> |
Linda King FRSB is a virologist in the UK. She is Professor of Virology and Pro Vice-Chancellor for Research and Global Partnerships at Oxford Brookes University.
King was a student at the University of Liverpool graduating with a BSc in Biochemistry and Cell Biology,[1] she studied for her doctorate in molecular virology at the University of Oxford graduating in 1985 and then worked as a postdoctoral researcher and junior research fellow at Linacre College.[2] The following year she moved to Oxford Brookes to work as a lecturer in virology and subsequently rose to professor in 1998.[3]
King's research looks at insect viruses and focusses on baculovirus expression systems[3] and their use in protein production.
In 1992 she wrote a book with Robert Possee, The Baculovirus Expression Vector System: A Laboratory Guide.[4]
In 2006 King co-founded Oxford Expression Technologies,[5] a spin out company of Oxford Brookes and NERC,[6] which uses a Baculovirus-based protein expression platform to develop mammalian virus vaccines.[7] In 2020 the company is involved in development of 'Covax-19', a vaccine against COVID-19.[8]